Arachidonylcyclopropylamide
From Wikipedia, the free encyclopedia
![]() |
|
Names | |
---|---|
IUPAC name
N-(Cyclopropyl)-5Z,8Z,11Z,14Z-eicosatetraenamide
|
|
Other names
ACPA
|
|
Identifiers | |
229021-64-1 ![]() |
|
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL418353 ![]() |
ChemSpider | 4470548 ![]() |
739 | |
PubChem | 5311007 |
|
|
|
|
Properties | |
C23H37NO | |
Molar mass | 343.56 g·mol−1 |
Solubility in other solvents | soluble in ethanol, chloroform, THF and DMSO |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
Arachidonylcyclopropylamide (ACPA) is a synthetic agonist of the cannabinoid receptor 1 (CB1R). ACPA is considered to be a selective cannabinoid agonist as it binds primarily to the CB1R and has low affinity to the cannabinoid receptor 2 (CB2R) (Ki = 2.2 nM for CB1R; Ki = 700 nM for CB2R).[1]